https://www.selleckchem.com/pr....oducts/n6-methyladen
There were no significant differences in the ORR between the two groups. The PFS, DSS, and OS significantly increased in the cats that received PRT alone compared to the cats that received PRT after chemotherapy failure (median PFS 336 vs 228 days, P = 0.0012, median DSS 360 vs 242 days, P = 0.0025, median OS 346 vs 242 days, P = 0.0036, respectively). The incidence rate of systemic disease significantly increased in 75% (12/16) of cats receiving PRT after chemotherapy failure compared to 41% (13/32) of cats receiving PRT alo
Beğen
Yorum Yap
Paylaş
